Search results
Moderna's (MRNA) Omicron-Specific Booster Jab Meets Study Goal
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA announced positive data from a phase II/III study, which evaluated its second...
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
Investor's Business Daily· 10 months agoThe biggest names in Covid are updating their vaccines for a fall campaign, but that might not be...
Fall Covid boosters works against the highly mutated BA.2.86 variant, vaccine makers say
NBC News via Yahoo News· 8 months agoModerna’s latest Covid booster appears to work against the BA.2.86 omicron subvariant, the drugmaker...
Here's When to Expect a 4th COVID-19 Booster Vaccine
Good Housekeeping via Yahoo News· 2 years agoNew COVID-19 booster shots targeted against Omicron subvariants will be rolled out across the U.S. in September. Here's when Americans can get their next...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 7 days agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 weeks agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
COVID boosters are now approved by the CDC. Experts answer questions about the new vaccine.
Yahoo Life Style via AOL· 8 months agoEverything you need to know about the new COVID booster. (Photo Illustration: Victoria Ellis for...
When Will It Be Time For Another COVID Booster? Here's What Experts Think.
HuffPost Life via Yahoo News· 2 years agoWe’ve seen second COVID-19 boosters recommended for older adults and people with underlying health...
The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna, Merck and GSK
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – October 14, 2022 – Zacks.com announces the list of stocks...
This Should Be a Wake-Up Call for Moderna Investors
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) has been a tremendous growth story in recent years, generating billions in revenue from its COVID-19 vaccine, its first commercial...